KCM
MED icon

Khrom Capital Management’s Medifast MED Stock Holding History

Khrom Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,417
Closed -$2.97M – 18
2021
Q3 		$2.97M Buy
15,417
+12,523
+433% +$3.08M 2.46% 14
2021
Q2 		$819K Buy
+2,894
New +$784K 0.76% 15

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Khrom Capital Management's MED Position: Q4 2021 in Review

Khrom Capital Management sold out of Medifast (MED) in Q4 2021, closing a stake of 15,417 shares — an estimated $2.97M sold.

Khrom Capital Management first reported a position in MED in Q2 2021 and held it in 2 quarters. The position peaked at $2.97M in Q3 2021. 297 funds tracked by Wall St. Rank hold MED as of Q4 2021.

  • Khrom Capital Management reported no remaining Medifast position as of Q4 2021 after selling out during the quarter.
  • Khrom Capital Management sold 15,417 Medifast shares in Q4 2021, an estimated $2.97M.
  • Khrom Capital Management first reported a position in Medifast in Q2 2021 and held it in 2 quarters.
  • Khrom Capital Management's Medifast position peaked at $2.97M in Q3 2021.
  • 297 funds tracked by Wall St. Rank held Medifast as of Q4 2021.

Based on Khrom Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.